These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1725611)

  • 1. [Immunologic aspects of thrombocyte transfusion].
    Mueller-Eckhardt C
    Beitr Infusionsther; 1991; 28():132-41. PubMed ID: 1725611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
    Kuntz BM; Wollenhaupt HJ; Brüster HT
    Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
    Barz D; Gatzka E; Kollmorgen I
    Beitr Infusionsther Transfusionsmed; 1996; 33():47-54. PubMed ID: 8974708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for managing refractoriness to platelet transfusions.
    Dan ME; Schiffer CA
    Curr Hematol Rep; 2003 Mar; 2(2):158-64. PubMed ID: 12901147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory response to platelet transfusion therapy.
    Eisenberg S
    J Infus Nurs; 2010; 33(2):89-97. PubMed ID: 20228646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk of immunization to blood cells and diagnostic and therapeutic implications].
    Kiefel V
    Beitr Infusionsther; 1993; 31():44-51. PubMed ID: 7693263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demonstration of platelet-specific alloantibodies in HLA-sensitized hematologic oncologic patients].
    Schnaidt M; Wernet D; Mayer G; Northoff H
    Beitr Infusionsther Transfusionsmed; 1994; 32():240-3. PubMed ID: 9480099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.
    Moazami N; Itescu S; Williams MR; Argenziano M; Weinberg A; Oz MC
    J Heart Lung Transplant; 1998 Sep; 17(9):876-80. PubMed ID: 9773859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of platelet specific antibody (anti-Sib(a)).
    Liu D; Lu P; Wang J; Bao Y
    Chin Med J (Engl); 1996 Aug; 109(8):615-7. PubMed ID: 9206062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients.
    Taaning E; Simonsen AC; Hjelms E; Svejgaard A; Morling N
    Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
    Lo SC; Chang JS; Lin SW; Lin DT
    Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies.
    Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S
    Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
    Sandler SG
    Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Substitution of thrombocyte concentrates in polytransfused patients].
    Mempel W; Böck M
    Beitr Infusionsther; 1993; 31():81-5. PubMed ID: 7693269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombocyte alloantigens].
    Panzer S
    Wien Klin Wochenschr; 1998 Jun; 110(12):423-7. PubMed ID: 9677661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic factors in reactions to blood transfusions.
    McLeod BC
    Heart Lung; 1980; 9(4):675-81. PubMed ID: 6773907
    [No Abstract]   [Full Text] [Related]  

  • 19. New paradigms in the management of alloimmune refractoriness to platelet transfusions.
    Vassallo RR
    Curr Opin Hematol; 2007 Nov; 14(6):655-63. PubMed ID: 17898571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human platelet alloantigens.
    Santoso S; Kiefel V
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):806-13. PubMed ID: 11732116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.